Delivery Order SPE2DB20D1100-SPE2DB25FD3C2
Award Date
7/9/25
Potential Completion Date
7/10/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,721.40 firm fixed price delivery order contract is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a period of performance through February 26, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a ceiling value of $37,579.10 and a performance period through March 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a $3,239.99 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, to provide 4566054689 DROXIDOPA 200 MG CAPSULE 90S. This contract has an ultimate completion date of October 9, 2024 and is not set aside for a specific socioeconomic program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,091,994 units of the prescription medication Droxidopa 100 mg capsules in 90-count packages. The contract has a ceiling value of $5,948.85 and a period of performance ending on May 1, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,756,328 units of the drug Droxidopa 100 mg capsules, which are used for the treatment of certain medical conditions. The contract has a firm fixed price of $23,689.00 and a completion date of February 26, 2024. The contract is not set aside for any specific business type....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,143,796 units of Droxidopa 300 mg capsules, a medication used to treat neurological conditions. The contract has a firm fixed price and a ceiling value of $30,036.24, with a performance period extending until May 6, 2025. The contract is not set aside for any specific...
This is a Delivery Order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $30,495.60 firm fixed price contract is for the supply of 90-count capsules of the drug droxidopa 200 mg. The award does not have a set-aside designation. This Delivery Order is placed against a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award SPE2DB20D3505|SPE2DB25FU0H8 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,405.58 firm fixed-price delivery order is for the supply of 4567304303 - DROXIDOPA 100 MG CAPSULE 90S, a specialty medication. The contract has an ultimate completion date of February 19, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of 4,564,359,527 units of the pharmaceutical product DROXIDOPA 100 MG CAPSULE 90S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $4,751.63, was awarded on April 22, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a firm fixed price pricing type and an ultimate completion date of April 23, 2024. This award is associated with a...
This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of medical products to the U.S. federal government. The $30,495.60 firm-fixed price contract is for the delivery of 90-count bottles of 200 mg Droxidopa capsules. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...